The transmembrane proton gradient (∆pH) is the primary source of energy exploited by secondary active substrate/H + antiporters to drive the electroneutral transport of substrates across the Escherichia coli (E. coli) inner membrane. Such electroneutral transport results in no net movement of charges across the membrane. The charge on the transported substrate and the stoichiometry of the exchange reaction, however, can result in an electrogenic reaction which is driven by both the ∆pH and the electrical (∆ψ) components of the proton electrochemical gradient, resulting in a net movement of electrical charges across the membrane. We have shown that the major facilitator superfamily transporter MdtM -a multidrug efflux protein from E. coli that functions physiologically in protection of bacterial cells against bile salts -imparts bile salt resistance to the bacterial cell by coupling the exchange of external protons (H + ) to the efflux of bile salts from the cell interior via an electrogenic antiport reaction (Paul et al., 2014). This protocol describes, using fluorometry, how to detect electrogenic antiport activity of MdtM in inverted membrane vesicles of an antiporter-deficient strain of E. coli TO114 cells by measuring transmembrane ∆ψ. The method exploits changes that occur in the intensity of the fluorescence signal (quenching and dequenching) of the probe Oxonol V in response to changes in membrane potential due to the MdtM-catalysed sodium cholate/H + exchange reaction. The protocol can be adapted to detect activity of any secondary active antiporter that couples the electrogenic translocation of H + across a biological membrane to that of its counter-substrate, and may be used to unmask otherwise camouflaged transport activities and physiological roles. Materials and Reagents 1. E. coli TO114 (gift of Prof. Hiroshi Kobayashi, Chiba University, Japan) 2. E. coli BW25113 (National BioResource Project, Japan) 3. pBAD/Myc-His A expression vector (Life Technologies, catalog number: V440-01) 4. L-(+)-arabinose (Sigma-Aldrich, catalog number: A3256) 5. Carbenicillin (Carbenicillin Direct) 6. Agar (Sigma-Aldrich, catalog number: A1296) 7. Tryptone (Fluka, catalog number: T7293) 8. Yeast extract (Fluka, catalog number: 92114)
Large ice bucket
3. Petri dishes for bacterial colony growth 4. 100 ml conical flasks 5. 250 ml conical flasks (x2) 6. 5,000 ml conical flask 7. Refrigerated, large capacity centrifuge and rotor for harvesting bacterial cells 8. 1,000 ml or 500 ml centrifuge pots and lids 9. Benchtop vortexer 10. 100 ml beaker and stir bar to fit 11. Magnetic stirrer 12. 25 ml disposable plastic pipettes 13. Selection of single channel pipettes (1,000 µl, 100 µl, 20 µl, 10 µl) 14. Pipette tips for above 15. Refrigerated centrifuge and rotor capable of spinning ~50 ml tubes at 18k x g. 1. Due to typically low levels of endogenous transporter expression, this method necessitates that the transporter of interest be overexpressed from a multicopy plasmid.
We therefore begin the protocol with a description of the conditions used specifically for overexpression of MdtM from the pBAD/Myc-His A expression vector; these conditions (for example, the vector type, inducer concentration, and growth temperature) will vary depending upon the transporter that requires to be overexpressed. Furthermore, although the protocol described here pertains to measurement of electrogenic bile salt (sodium cholate) transport by MdtM specifically, it can be readily adapted for measurement of the electrogenicity of transport by other secondary active antiporters. Typically, a 1 L culture of bacterial cells will provide sufficient material for these experiments.
2. Perform a fresh transformation with the pBAD/Myc-His A plasmid DNA encoding wild type or mutant transporter (or your vector of choice encoding your transporter of interest) into chemically competent E. coli TO114 cells. Plate the cells onto Luria Bertani Potassium (LBK) agar containing 100 μg/ml carbenicillin for selection. LBK agar must be used instead of regular Luria Bertani (LB) agar because the latter contains NaCl and the TO114 strain is sensitive to this salt due to deletion of the chromosomally encoded Na + /H + antiporter NhaA. Incubate the plate overnight (~15 to ~18 h) at 37 °C.
3. Pick a few single colonies from the agar plate and use to inoculate 2 x 250 ml conical flasks, each containing 100 ml of LBK liquid medium supplemented with 100 μg/ml carbenicillin. Grow the cultures overnight (~15 h) at 30 °C with 250 rpm shaking in a temperature-controlled shaking incubator. Measure the optical density at 600 nm (OD600) of the culture using a spectrophotometer; it should be between 3.0-3.3. If the OD600 is less than 3.0, then incubate for a further 0.5-1.0 h and re-measure. If the OD600 is greater than 3.3, the cultures have overgrown and fresh cultures will need to be prepared. 4. Inoculate a 5 L conical flask containing 1,000 ml of LBK liquid medium supplemented with 100 μg/ml carbenicillin with 15 ml of overnight culture. Incubate at 32 °C with 270 rpm shaking for ~2.5 hrs in a temperature-controlled shaking incubator. The OD600 should be ~0.6. Drop the temperature to 25 °C and grow with 270 rpm shaking until the OD600 is 1.0.
This usually takes between 0.5 to 1.0 h. 5. Induce overexpression of MdtM by addition of 0.1% w/v L-(+)-arabinose [5 ml of 20% w/v L-(+)-arabinose] to the culture. After addition of arabinose, grow the cells for a further 1.5 h at 25 °C with 270 rpm shaking prior to harvesting. 6. Transfer the E. coli TO114 cells that contain overexpressed transporter into 500 ml or 1,000 ml capacity centrifuge pots that have been pre-chilled on ice for at least 15 min.
Pre-cool the centrifuge to 4 °C and harvest cells by centrifugation at 5,000 x g for 20 min. 7. Decant the supernatant and wash the pelleted cells by resuspending (either by gentle vortexing using a benchtop vortexer or by gentle aspiration using a 25 ml sterile plastic Copyright © 2014 The Authors; exclusive licensee Bio-protocol LLC. pipette) in chilled (4 °C) TSDS buffer. Use 30 ml of TSDS buffer for each one litre of cell culture that was pelleted. Maintain the cells on ice during this procedure. Harvest the washed cells by centrifugation as described in step A1 (above) and repeat the washing procedure. Resuspend the resultant cell pellet in 30 ml of chilled TSDS buffer containing 2 mM PMSF (Which should be made up as a 100 mM stock in ethanol and stored at -20 °C; ensure the solution is thawed thoroughly and vortexed vigorously before use.) and 5 µM DNase and maintain the mixture on ice.
8. Decant the resuspended cells into a 100 ml beaker containing a stir bar, place on a magnetic stirrer and stir in a cold room at 4 °C for 20 min. Alternatively, place the beaker on ice in an ice bucket, place on the magnetic stirrer and stir for 20 min. 9. The method for production of inverted vesicles relies on a combination of the fluid shear forces and decompression created as the cell mixture passes through the needle valve of a French pressure cell. Generate inverted membrane vesicles by a single passage of the resuspended cell mixture through a French pressure cell at a minimum of 4,000 psi. If the pressure is too low, inverted vesicles will not be formed. The pressure cell should be chilled on ice for ~30 min prior to use. The resulting inverted vesicle mixture should be collected in a 100 ml conical flask kept on ice.
10. Decant the mixture into a pre-chilled ~50 ml centrifuge tube and remove any unbroken cells and cell debris by centrifugation at 18,000 x g for 10 min at 4 °C. Carefully decant the supernatant containing the cell membrane vesicles (do not disturb the pellet that contains unbroken cells and cell debris) into a pre-chilled 30-50 ml volume polycarbonate ultracentrifuge tube on ice.
11. Harvest the inverted vesicles by ultracentrifugation at 100,000 x g for 1 h at 4 °C.
Carefully decant the supernatant and retain the pellet. Place the ultracentrifuge tube containing the pelleted vesicles on ice.
12. Thoroughly resuspend the inverted vesicle pellet in 1 ml of ice-cold TSDS buffer by gentle aspiration using a 1,000 µl pipette. Transfer the resuspended vesicles to a prechilled 1.5 ml Eppendorf tube on ice for use in the transport assay. In our experience, vesicles stored on ice are stable for several hours.
13. Quantify the total membrane protein content of the inverted vesicles by UV absorbance spectroscopy at 280 nm. Blank the spectrophotometer using a 10 mm pathlength quartz cuvette containing 1,000 µl of TSDS buffer. The buffer should be at room temperature to prevent frosting of the cuvette faces. Clean the faces of the cuvette using a fresh paper wipe prior to measurement. Once the spectrophotometer is blanked, remove 5 µl of buffer from the cuvette using a 10 µl pipette and replace with 5 µl of vesicles. Cover the opening of the cuvette with a square of Parafilm and invert the cuvette a few times to ensure a homogeneous distribution of vesicles. Record the absorbance of the vesicle mixture at 
Notes
1. Resuspended inverted vesicles from step A8 can be transferred to tubes in aliquots of 25-100 µl, snap-frozen in liquid nitrogen and stored at -80 °C for subsequent use.
Vesicles frozen in this way will retain their integrity for several months. However, if frozen vesicle stocks are used for the subsequent transport measurements, the vesicles must be thawed very slowly on ice prior to use to prevent their fracture. 4. As with all assays that rely on detection of fluorescence, robust controls must be in place to ensure that any detected transport activity can be attributed unambiguously to the protein of interest. In our experiments, we used inverted vesicles that overexpressed MdtM D22A, a dysfunctional point mutant of MdtM, as a negative control (see Figure 1b ).
5.
If the method is to be used for detection of metal ion/H + antiport activity, the use of inverted vesicles generated from the antiporter-deficient TO114 strain of E. coli is important because at least four other transporters (NhaA, NhaB, ChaA and MdfA) present in the bacterium can catalyse a monovalent metal cation/H + exchange.
6. Because chloride ions can depolarise the membrane potential, all buffer systems must be maintained as chloride-free. Therefore, pH of buffers should be adjusted using H2SO4 instead of HCl.
7. Finally, if this protocol is used for comparison of antiport activities of wild type and mutant transporters, the amount of target protein present in the inverted vesicle membranes must be quantified (usually by immunodetection methods) to ensure that any measured differences in H + uptake are due solely to differences in the activity of the transporters and not to differences in expression levels. Copyright © 2014 The Authors; exclusive licensee Bio-protocol LLC. 
